The EU is moving toward MoA-based pediatric planning, following the precedent set by the RACE Act in the US. This approach promises better outcomes for children and more innovative medicines, but it requires early, integ...

Learn the pros and cons of different AI models for SaMDs. The right model and data training sets are essential to develop your AI-enabled device. Our latest whitepaper lays out the best practices for data and AI models...

What should you consider when choosing a training dataset for your AI-enabled SaMD? Our whitepaper has the answers. Learn about AI models and data best practices and plan for your FDA Pre-Sub. Download it today. https://...

PubsHub Journals & Congresses makes it faster and easier for your team to identify the ideal publication venue for your work. With advanced search capabilities across 5,500+ journals and 4,400+ congresses, and over 50 me...

Fast‑moving regulation demands clear, compliant storytelling. Ground campaigns in approved labelling and use the FDA’s newly published CRLs to pre‑empt pitfalls and sharpen claims—across every channel. Read ICON’s lat...

“Change is accelerating — and it shows no signs of slowing down. For pharmaceutical companies, this environment does not call for panic, it calls for preparation.” Fast‑moving regulation demands clear, compliant storyt...

ICON received a range of prestigious awards and brand recognition in 2025. Learn more: https://ow.ly/T0kr50XSPGH

Missed our recent webinar from Symphony Health, an ICON plc company? The recording for Riding the data wave: How pharma can navigate disruptions in open claims is now available. Discover how life sciences organisatio...

The annual J.P. Morgan Healthcare Conference convenes thousands of healthcare investors, global industry leaders and technology innovators to explore the key trends shaping the industry in 2026 and beyond. If you would ...

Demographic Matching in Organ Impairment Studies: Why It Matters Organ impairment (OI) studies are critical for safe and effective drug development—but did you know that demographic matching can make or break the accurac...

Integrating modern technologies and careful preparation can contribute significantly to supporting and enhancing the performance of the people who make cardiovascular outcome trials function. Read the article for human-c...

Innovation is accelerating progress in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions bring together advanced formulation design, real-time dose flexibility, and world-class CMC expertise to si...